Inhalers are just as safe without chlorofluorocarbons

The need to monitor the safety of new medicines in large populations of patients is well established. Ayres et al (p 926) conducted a postmarketing surveillance study of the safety of the first licensed, pressurised metered dose inhaler to use a non-chlorofluorocarbon propellant---the hydrofluoroalkane 134a salbutamol sulphate inhaler (Airomir, 3M)---in primary care. They observed outcomes in over 6000 patients who had been prescribed metered doses of salbutamol delivered by inhalers using either hydrofluoroalkane or chlorofluorocarbon as the propellant. Their findings supported the experience of clinical trials, showing that the reformulation does not result in significant changes in safety compared with metered dose inhalers using non-chlorofluorocarbon propellants.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines
J G Ayres, C D Frost, W F Holmes, D R R Williams, and S M Ward
BMJ 1998 317: 926-930. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ